A predictive model of inappropriate use of medical tests and medications in Bronchiolitis

Jefferson Antonio Buendía1,2,3, Carlos Andrés Rodríguez1,2,3

  • 1Grupo de Investigación en Farmacología y Toxicología (INFARTO), Universidad de Antioquia, Medellín, Colombia.

Insights

Inappropriate medication and test use in bronchiolitis is common. Longer hospital stays increase this risk, while fever and high white blood cell counts at admission decrease it.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Clinical Pharmacology

Background:

  • Bronchiolitis is a common respiratory infection in infants.
  • Inappropriate use of medications and diagnostic tests in bronchiolitis is a concern.
  • Predictors for this inappropriate use require further investigation.

Purpose of the Study:

  • To identify factors associated with the inappropriate use of medications and medical tests in infants hospitalized with bronchiolitis.
  • To analyze the prevalence of specific medications and tests prescribed during bronchiolitis admissions.

Main Methods:

  • Retrospective study of 1930 infants under two years old admitted with bronchiolitis (January 2015 - December 2018).
  • Defined a composite score for inappropriate medication and test use.
  • Statistical analysis controlled for potential confounders.

Main Results:

  • Nebulized hypertonic saline (92.6%), albuterol (56%), and antibiotics (26.4%) were frequently prescribed.
  • Hemogram (95.9%), chest X-rays (92.2%), and C-reactive protein (79.8%) were commonly ordered tests.
  • Longer hospital stay increased inappropriate use risk (OR 1.29). Absence of fever (OR 0.22) and leukocytosis (OR 0.09) decreased this risk.

Conclusions:

  • Inappropriate use of diagnostic tests and drugs for bronchiolitis is highly prevalent.
  • Factors increasing risk include longer hospitalizations.
  • Factors decreasing risk include absence of fever and normal white blood cell count upon admission.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
826
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
550
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
680
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
610